<DOC>
<DOCNO>EP-1047677</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Process for the preparation of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D25700	C07D25702	A61B5055	G01R3344	C07F96524	C07D48700	C07F900	A61K4906	A61K4900	A61K4906	G01R3344	G01R3328	C07D48708	A61B5055	A61K4900	G01R3328	C07F938	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	A61B	G01R	C07F	C07D	C07F	A61K	A61K	A61K	G01R	G01R	C07D	A61B	A61K	G01R	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D257	C07D257	A61B5	G01R33	C07F9	C07D487	C07F9	A61K49	A61K49	A61K49	G01R33	G01R33	C07D487	A61B5	A61K49	G01R33	C07F9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Compounds of general formula (I), in which R is hydrogen, a straight or branched or cyclic C1-C6 alkyl group, unsubstituted or substituted by 1 to 10 oxygen atoms, or a C1-C20 alkyl group, optionally interrupted by a phenylene, in its turn substituted by a straight or branched C1-C6 alkyl group, unsubstituted or substituted 1 to 3 C1-C7 groups; the aromatic group being unsubstituted or substituted by alkoxy, carboxy, sulfamoyl, hydroxyalkyl, amino groups; as well as their complexes with bi- trivalent metal ions having atomic number variable from 20 to 31, 39, 42, 43, 44, 49, or from 57 to 83, as well as their salts with anions of physiologically acceptable organic acids.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
The present invention relates to a process for the preparation of
1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives
of formula (I).
In particular the present invention relates to the preparation
of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid of formula (X),
The compounds of general formula (I), and in
particular the compound of formula (X), are
chelating agents for bi- trivalent metal ions and are 
also important intermediates for the synthesis of
1,4,7,10-tetraazacyclododecane derivatives chelating
agents, symmetrically functionalized at the 1- and 4-positions.The starting material for the preparation of mono- or multidentate
tetraazacyclododecanes is generally represented by 1,4,7,10-tetraazacyclododecane.EP 0 545 511 A2 discloses a process for the preparation of mono-N-substituted-1,4,7,10-tetraazacyclododecanes
which comprises the alkylation of 1,4,7,10-tetraazacyclododecane.EP 0 872 479 A1 and WO 89/05802 disclose tri- and tetraacetic 1,4,7;10-tetraazacyclododecane
derivatives, which can be prepared from suitable substituted
1,4,7,10-tetraazacyclododecanes by reaction with a carboxylic acid bearing a
leaving group on the alpha-carbon. The preparation of 1,4,7,10-tetraazacyclododecane
1,4,7,10-α,α',α",α'''-tetrakis(methylacetic acid) is disclosed
in EP 0481 420 A1.WO 95/05118 discloses polyamino paramagnetic chelates containing both
phosphonate and non-phosphonate moieties. In particular, the preparation of N,N'-bis(carboxymethyl)-N",N'''-bis(dihydroxyphosphorylmethyl)-1,4,7,10-tetraazacyclododecane
by subsequently reacting 1,4,7,10-tetraazacyclododecane
eith diethylphosphite and bromoethylactetate is reported.WO 95/09161 discloses 1,4,7,10-tetraazacyclododecane macrocycles containing at
least one fused cyclohexyl ring obtainable by reacting suitable 1,4,7,10-tetraazacyclododecane
precursors with acetic acid derivatives.EP 0 448 191 A1 discloses tri-acetic acid derivatives of 1,4,7,10-tetraazacyclododucane-butyltriol
obtainable by alkylation of 1,4,7,10-tetraazacyclododecane.Alternative approaches to the synthesis of 1,4,7,10-tetraazacyclododecane
derivatives are disclosed in WO 99/05128 and WO 99/05145: the former discloses
the preparation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
derivatives and of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid derivatives
from 2a,4a,6a,8a-decahydrotetraazacyclopent[fg]acenaphthylene, the latter
discloses 1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-2-one and the use thereof for the
preparation of tri- and
</DESCRIPTION>
<CLAIMS>
A process for the preparation of compounds of formula (I),


in which

R
is a hydrogen atom, a straight or branched or cyclic C
1
-C
6

alkyl group, unsubstituted or substituted by 1 to 10
oxygen atoms, or a C
1
-C
20
 alkyl group, optionally
interrupted by a phenylene, in its turn substituted by a

straight or branched C
1
-C
6
 alkyl group, unsubstituted or
substituted by 1 to 3 C
1
-C
7
 groups; the aromatic group
being unsubstituted or substituted by carboxy, sulfamoyl,

hydroxyalkyl, amino groups

comprising the steps represented in Scheme 1: 

a) condensation of triethylenetetramine (II) with a glyoxal
derivative, in water or in water-soluble solvents or in

mixtures thereof, at a temperature of 0-50°C, in the
presence of a stoichiometric amount or a slight excess of

calcium hydroxide to give octahydro-3H,6H-2a,5,6,8a-tetraazacenaphthylene
(III);
b) condensation of compound (III) with an alkylating agent
X-CH
2
-CH
2
-X, in which X is Cl or Br in amounts from 1 to 5
mols per mol of compound (III), in a dipolar aprotic

solvent and in the presence of a base selected from alkali
or alkaline-earth metal carbonates, in amounts from 5 to

10 mols per mol of compound (III), and with the addition
of NaY, wherein Y is I or Br, as catalyst in amounts from

0.1 to 2 mols per mol of compound (III), wherein X and Y
are not at the same time Br, at a temperature from 25 to

150°C, to give decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]ace-naphthylene

of formula (IV);
c) oxidation of compound (IV) with bromine at pH 4-5 to give
2,3,4,6,7,8-hexahydro-1H,5H-4a,6a-diaza-2a,8a-azoniacyclopent[fg]
acenaphthylene
dibromide of formula

(V);
d) addition of perchlorate ions to the solution of compound
(V) to give 2,3,4,6,7,8-hexahydro-1H,5H-4a,6a-diaza-2a,8a-azoniacyclopent[fg]
-acenaphthylene
diperchlorate (VI),


poorly water soluble
; 
e) alkylation of compound (VI) with an alkylating agent of
formula R-CH(X)COOH, in which X is a halogen, and R is

defined as above, in basic conditions, to give the
compounds.of formula (VII);
f) hydrolysis of the formyl group of the compounds (VII) in
basic conditions to give the novel compounds of formula

(VIII);
g) alkylation of compound (VIII) with the alkylating agent of
formula R-CH(X)-COOH, in which X and R have the meanings

defined above, in basic conditions, to give the compounds
of formula (IX);
h) hydrolysis of compounds (IX), in basic conditions, to give
the compounds of formula (I).
A process according to claim 1 for the preparation of
compounds of formula (I), in which R is selected from the group

consisting of: H or a straight or branched alkyl group, such as
a methyl, ethyl, propyl, isopropyl, butyl, isobutyl group, in

its turn substituted by hydroxy groups or interrupted by oxygen
atoms; or, when an aromatic group is present in R, R is

selected from phenyl and benzyl.
A process according to claim 2 for the preparation of a
compound selected from the group consisting of: 1,4,7,10-tetraazacyclododecane-1,4-diacetic

acid; α,α'-dimethyl-1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid; α,α'-diethyl-1,4,7,10-tetraazacyclododecane-1,4-diacetic

acid; α,α'-dibenzyl-1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid. 
A process according to claim 3 for the preparation of
1,4,7,10-tetraazacyclododecane-1,4-diacetic acid.
A process as claimed in any one of claims 1-4, in which in
step b) the alkylating agent is added in amounts from 1 to 5

mols per mol of compound (
III
), at temperatures from 30 to
80°C;

in step c) the oxidation is carried out adding bromine in
amounts of 2 - 2.5 mols per mol of compound (IV), in aqueous

solution at pH 4 - 5, at temperatures from 17 to 30°C;

in step d) sodium perchlorate or perchloric acid are added in
amounts of 2.5 - 3 mols per mol of compound (IV);

in step e) the reaction temperature ranges from 30 to 70°C, pH
ranges from 10 to 12 and is obtained by addition of a base; the

amount of alkylating agent is stoichiometric or in excess;

step f) is the hydrolysis of compounds (VII) in aqueous
solution at basic pH, at temperatures from 50 to 100°C;

step g) is effected as already described for step e);

step h) is the hydrolysis of compounds of formula (IX) in
aqueous solution at basic pH, obtained by addition of 3 - 7

mols of a base, at temperatures of 150-220°C.
A process according to 
any one of
 claims 
1 - 5
, in which,
in the alkylating agent of formula R-CH(X)-COOH, X is bromine

or chlorine.
A process for the preparation of 1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid as claimed in

claim 
4
, in which in steps e) and g) the alkylating agent of 
formula R-CH(X)-COOH is the compound of formula XCH
2
COOH and X
is chlorine or bromine.
A process as claimed in claim 7, in which the alkylating
agent in steps e) and g) is BrCH
2
COOH, added in amounts of at
least 1.5 mols of alkylating agent per mol of starting product,

at temperatures of 45°C and at pH 11.5, 
for a reaction time of
21 hours
.
A process for the preparation of 1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid as claimed in

claim 4, in which compound (V), or compound (VI) 
is directly
alkylated
 with at least 4 mols of BrCH
2
COOH 
per mol of starting
product
, at a temperature of 90°C and at basic pH.
Compound of formula (VII), as intermediate in the process
according to claims 1 - 9.



in which R is as defined in claim 1.
7-Formyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid of formula (VIIa), as claimed in claim 
10
, in which
R is hydrogen, as intermediate in the preparation of 1,4,7,10-tetraazacyclododecane-1,4-diacetic

acid. 

A compound as claimed in claim 10, selected from the group
consisting of:


α-methyl-7-formyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid in which R is the methyl group;
α-ethyl-7-formyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid in which R is the ethyl group;
α-benzyl-7-formyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid in which R is the benzyl group.
A compound of general formula (VIII), as intermediate in
the process according to claims 1 - 9.



in which R is as defined in claim 1.
1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid of formula (VIIIa), as claimed in claim 13, in which R is
a hydrogen atom, as intermediate in the process for the 

preparation of 1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid.


A compound as claimed in claim 13, selected from the group
consisting of:


α-methyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid, in which R is the methyl group;
α-ethyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid, in which R is the ethyl group;
α-benzyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4-acetic

acid, in which R is the benzyl group.
A compound of formula (IX), as intermediate in the process
according to claims 1 - 9.



in which R is as defined in claim 1.
1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-13-on-4,7-diacetic

acid of formula (IXa), as claimed in claim 16, in
which R is a hydrogen atom, as intermediate in the process for 

the preparation of 1,4,7,10-tetraazacyclododecane-1,4-diacetic
acid.


A compound as claimed in claim 16, selected from the group
consisting of:


α,α'-dimethyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4,7-diacetic

acid, in which R is the methyl group;
α,α'-diethyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4,7-diacetic

acid, in which R is the ethyl group;
α,α'-dibenzyl-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-13-on-4,7-diacetic

acid, in which R is the benzyl group.
A process according to claim 1 in which step d) is omitted
and compound (V) is directly alkylated according to step e), to

give compound (VII).
A process as claimed in claim 19, for the preparation of
1,4,7,10-tetraazacyclododecane-1,4-diacetic acid, in which R is

a hydrogen atom.
A process according to claim 1 further comprising
alkylation of compounds (I) with an excess of an alkylating

agent R
1
-CH(X
1
)-COY of formula (XIV), to give of compounds
(XIII) 



in which

R
have the meanings as defined above;
R
1
is a hydrogen atom, a straight or branched or cyclic
C
1
-C
6
 alkyl group, unsubstituted or substituted by 1
to 10 oxygen atoms, or a C
1
-C
20
 alkyl group,
optionally interrupted by a phenylene, phenyleneoxy

or phenylenedioxy in its turn substituted by a
straight or branched C
1
-C
6
 alkyl group, unsubstituted
or substituted by 1 to 7 hydroxy groups or 1 to 3 C
1
-C
7

groups; the aromatic group being unsubstituted or
substituted by alkoxy groups or by halogens, carboxy,

carbamoyl, alkoxycarbonyl, sulfamoyl, hydroxyalkyl,
amino, acylamino, acyl, hydroxyacyl;
X
1
is a halogen or a sulfonic acid reactive residue;
Y
is a -OH, or -OR
2
 group, wherein
R
2
is a straight or branched C
1
-C
4
 alkyl group; when Y
is -OR
2
, the ester groups are hydrolysed to obtain
compounds of formula (XIII).
A process as claimed in claim 21, in which the alkylating
agent of formula (XIV) is a compound of formula R
1
-CH(X
1
)-COOH,
in which X
1
 is bromine or chlorine and R
1
 is selected from the 
group consisting of: H or a straight or branched alkyl group,

such as a methyl, ethyl, propyl, isopropyl, butyl, isobutyl in
its turn substituted by hydroxy groups or interrupted by oxygen

atoms.
A process as claimed in claim 22, in which the alkylating
agent of formula (XIV) is a compound of formula R
1
-CH(X
1
)-COOH,
in which R
1
 is hydrogen and X
1
 is bromine or chlorine.
A process as claimed in claim 22, in which the alkylating
agent of formula (XIV) is selected from the group consisting

of: bromoacetic acid, 2-bromopropionic acid, 2-bromobutyric
acid.
A process as claimed in claim 21, in which, in the
alkylating agent of formula (XIV), R
1
 is selected from the
group consisting of: phenyl, benzyl, phenylmethoxymethyl; X
1
 is
selected from the group consisting of: mesylate,

benzenesulfonyloxy, nitrobenzenesulfonyloxy, tosylate,
triflate; R
2
 is selected from the group consisting of: methyl,
ethyl, isopropyl, butyl, tert-butyl.
A process according to claims 24 and 25, for the
prepa
ration of α,α'-bis(methyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic
acid and of α,α'-bis

[(phenylmethoxy)methyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic
acid.
A process according to claim 1 further comprising reacting
a compound of formula (I) with formaldehyde and phosphorous 

acid (H
3
PO
3
) to give 1,4,7,10-tetraazacyclododecane-1,4-diacetic-7,10-dimethylenediphosphonic
acid of formula (XV).


The use of compounds (VII), (VIII) and (IX) as
intermediates in the process according to claim 1.
</CLAIMS>
</TEXT>
</DOC>
